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Abstract
Psychological, physical, and/or immune stressors during pregnancy are associated with negative
birth outcomes, such as preterm birth and developmental abnormalities. In rodents, prenatal
stressors can alter the expression of 5α-reductase enzymes in the brain and may influence
cognitive function and anxiety-type behaviour in the offspring. Progesterone plays a critical role in
maintaining gestation. Here it was hypothesised that 5α-reduced progesterone metabolites
influence birth outcomes and/or the cognitive and neuroendocrine function of the offspring. 5α-
reduced steroids were manipulated in pregnant Long-Evans rats via administration of vehicle, the
5α-reduced, neuroactive metabolite of progesterone, 5α-pregnan-3α-ol-20-one (3α,5α-THP,
allopregnanolone; 10 mg/kg/ml, SC), or the 5α-reductase inhibitor, finasteride (50 mg/kg/ml, SC),
daily from gestational days 17–21. Compared to vehicle or 3α,5α-THP treatment, finasteride,
significantly reduced the length of gestation and the number of pups per litter found in the dams’
nests after parturition. The behaviour of the offspring in hippocampus-dependent tasks (object
recognition, open field) was examined on post-natal days 28–30. Compared to vehicle-exposed
controls, prenatal 3α,5α-THP treatment significantly increased motor behaviour in females
compared to males, decreased progesterone content in the medial prefrontal cortex (mPFC) and
diencephalon, increased 3α,5α-THP and 17β-estradiol content in the hippocampus, mPFC, and
diencephalon, and significantly increased serum corticosterone concentrations in males and
females. Prenatal finasteride treatment significantly reduced object recognition, decreased
hippocampal 3α,5α-THP content, increased progesterone concentration in the mPFC and
diencephalon, and increased serum corticosterone concentration in female (but not male) juvenile
offspring, compared with vehicle-exposed controls. Thus, inhibiting formation of 5α-reduced
steroids during late gestation in rats reduces gestational length, the number of viable pups/litter,
and impairs cognitive and neuroendocrine function in the juvenile offspring.
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Introduction
Prenatal stress can have negative effects on birth outcomes and has been implicated in
preterm birth (parturition prior to 37 weeks of gestation in women) [1]. Environmental
stressors associated with low socio-economic status (such as unemployment, crowded urban
living conditions) are associated with low birth-weight and/or preterm birth in women [2].
More than a two-fold increase in the incidence of preterm birth has been reported among
pregnant women residing in an area severely hit by hurricane Katrina, compared to pregnant
survivors in an area that was less severely damaged [3]. The consequences of preterm birth
include greater fetal mortality and, among surviving offspring, neurological and
developmental disabilities [4,5]. Moreover, impairment of cognitive, social, and emotional
development has been observed in school-age children that were born preterm [6,7], and the
severity of these phenotypes is increased when gestation is shorter [6]. Maternal stress has
been reported to result in similar neurodevelopmental impairments in full-term infants [8,9]
to those observed following preterm birth, suggesting that they may have common
underlying causes. Despite the potential contributions of stress, the etiopathology of preterm
birth and/or associated effects on negative birth outcomes are not well understood. Further,
the mechanisms that mediate stress-related influences on pregnancy, parturition onset, and
birth outcomes need to be better understood.
Progestogens are critical for maintaining pregnancy [10] and also importantly influence
function of the major neuroendocrine stress response system, the hypothalamo-pituitary-
adrenal (HPA) axis. Progesterone is metabolised by 5α-reductase to form
dihydroprogesterone (DHP), which is subsequently converted to the neuroactive metabolite,
5α-pregnan-3α-ol-20-one (3α,5α-THP; also known as allopregnanolone) by the actions of
3α-hydroxysteroid dehydrogenase. In women, circulating concentrations of progesterone
and its metabolites increase as gestation progresses and their decline occurs concurrent with
parturition [11,12]. Studies using rodent models have revealed that central concentrations of
progesterone decline earlier in pregnancy than central concentrations of 3α,5α-THP, and it is
the 3α,5α-THP decline in the brain that is most proximately associated with parturition [13].
Hence, 3α,5α-THP may serve an important regulatory role, not only in the maintenance of
pregnancy, but also in the onset of parturition via its withdrawal.
In addition to effects on pregnancy, progestogens have activational effects to facilitate social
interaction, reduce stress axis responding, and exert anti-anxiety, cognitive enhancing and
neuroprotective effects [14]. Despite pregnancy and early exposure to maternal progestogens
being the sine qua non, the organizing role of progestogens is not well understood. While
there is little direct evidence that stress exposure during pregnancy alters 3α,5α-THP
formation, prenatal stressors alter the expression of 5α-reductase in the brain of sheep
offspring [15] and can have detrimental effects on cognitive function and anxiety-type
behaviour [16,17]. Moreover, rats that are bred for high anxiety responses to maternal
separation show differences in anxiety, reproductive behavior, and 3α,5α-THP levels in
midbrain compared to their low-anxiety conspecifics [18]. Moreover, perinatal
administration of supra-physiological levels of 3α,5α-THP ameliorates neonatal anxiety and
adult depressive-type behavior in this model [19]. Thus, in addition to activating effects in
adult, these findings may indicate a pervasive, organizational role for 3α,5α-THP on
offspring neurodevelopment.
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The present study investigated the role of a 5α-reduced, progesterone metabolite, 3α,5α-
THP, on pregnancy maintenance, birth outcomes and offspring neurodevelopment. Given
that progestins are presently utilized as tocolytic agents [20], it is important to understand
not only the immediate consequences of effects of 3α,5α-THP on pregnancy outcomes, such
as length of pregnancy and fecundity, but also the long-term neuroendocrine and
behavioural consequences for the gestationally-exposed offspring. We exposed pregnant rat
dams to either vehicle (oil), 3α,5α-THP (10 mg/kg), or the 5α-reductase inhibitor, finasteride
(50 mg/kg), on gestational days (GD) 17–21. Pregnancy outcomes (gestational length and
the number of viable offspring) were assessed, as well as cognitive, affective, and motor
function in the juvenile offspring. Endogenous progestogen (progesterone, DHP, 3α,5α-
THP), and 17β-estradiol contents were measured in blood and in brain regions important in
affective and cognitive function, and/or stress processing). We hypothesised that
administration of 3α,5α-THP would prolong gestation, whereas inhibition of 3α,5α-THP
formation via finasteride would reduce the length of gestation. Moreover, we anticipated
that 3α,5α-THP would not alter pup viability, but would enhance anti-anxiety-type/cognitive
behaviour of offspring, while finasteride would reduce pup viability, enhance anxiety-type
behaviour and impair cognitive function of surviving offspring, concomitant with altered
progestogen formation in the brains of the offspring.
Materials and Methods
Ethical Approval
These methods were pre-approved by the Institutional Care and Use Committee at The
University at Albany-SUNY and were conducted in accordance with ethical guidelines
defined by The National Institutes of Health (NIH Publication No. 85-23).
Animals and housing
Subjects were primigravid, timed-pregnant, adult female Long-Evans rats (N = 24)
purchased from Taconic Farms (Germantown, NY). Rats were packed on gestational day
(GD) 14, shipped on GD 15, and were housed in a temperature- (21 ± 1 °C) and humidity-
controlled room in the Life Sciences Research Building Laboratory Animal Care Facility at
The University at Albany-SUNY. Rats were group-housed (3–4/cage) until GD 18, after
which they were singly-housed. The housing room was maintained on a reverse 12:12 h
light cycle (lights off at 08:00 h) and rats were given ad libitum access to Purina Rat Chow
and water.
Evaluation of Pregnancy Status and Fecundity
Pregnancy status and duration of gestation were assessed daily. All rats were handled,
examined, and weighed from GD 16 until the day of parturition. Criteria for confirmation of
pregnancy were weight gain of > 5 g per day, with visible teats, and palpable pups. Rats not
meeting these criteria were excluded from the study (n = 3). The cages of all rats were
checked for pups hourly from 06:00 to 22:00 h daily from GD 18–23. The number of hours
after 00:00 h on GD 18 that pups were first observed was recorded as the latency to deliver.
GD 18 was chosen as this is the earliest time that we have observed prenatal manipulations
to promote parturition [21]. The number of pups in the nest following the completion of
parturition was counted and recorded, as a measure of pup viability. No dead pups were
found in the nest immediately following parturition or at any other time-points during the
study.
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Procedure
Assessment of Enhanced or Inhibited 3α,5α-THP Milieu on Gestational
Outcome—In order to assess the role of 3α,5α-THP on gestational outcome, 3α,5α-THP
availability was enhanced or inhibited on GD 17–21. Control dams (n = 7) were
administered vehicle (10% EtOH in vegetable oil, 0.1 ml/100 g, SC), daily on GD 17–21.
Some dams (n = 7) were administered a subcutaneous (SC) injection of 3α,5α-THP (10 mg/
kg/ml; Sigma-Aldrich Corp., St. Louis, MO) in vegetable oil (10% EtOH), daily on GD 17–
21. Some dams (n = 7) were administered the 5α-reductase inhibitor, finasteride (50 mg/kg/
ml, SC) in vegetable oil (10% EtOH), daily on GD 17–21. In rodents, finasteride inhibits the
type I 5α-reductase isozyme acutely and competitively binds irreversibly to the type II
isozyme [22]. We have observed that the present regimen reduces the production of 3α,5α-
THP from progesterone by ~50–75% [23]. Others have utilised this regimen in rats to
demonstrate that it allows for maintenance of pregnancy [24,25]. Manipulations were
conducted on GD 17–21 given that this period represents a critical time for the development
of offspring cortico-limbic structures [17,26,27]. Moreover, late pregnancy represents a time
when endogenous protective factors (such as maternal progestogens [13] and placental 11β-
hydroxysteroid dehydrogenase [28]) are declining, which may promote vulnerability to the
harmful effects of elevated glucocorticoid levels. We have previously observed that
maternal stress during this time can reduce the length of offspring gestation in rats, reduce
synaptic density in dorsal hippocampus of juvenile offspring, and yields poorer cognitive
outcomes for juvenile offspring [16,17].
Phenotype of Offspring—Following parturition, all pups were cross-fostered to non-
manipulated dams that were matched for postpartum stage in order to minimise potential
confounds produced by any aberrant maternal behaviour (reviewed in [29]). To achieve this,
litters were culled following birth, such that 15 males and 15 females per condition could be
cross-fostered to non-manipulated dams. The female-to-male ratios prior to culling did not
differ significantly across prenatal treatments (assessed via χ2 analysis), and were 1.1: 1.0
for vehicle-exposed control offspring, 0.8: 1.0 for 3α,5α-THP-exposed offspring, and 1.4:
1.0 for finasteride-exposed offspring. Litter birth weights were not assessed. For cross-
fostering, 2–4 pups were taken from each litter (i.e. either 1 male and 1 female, 1 male and 2
females, 2 males and 1 female, or 2 males and 2 females, in a counter-balanced manner) and
cross-fostered to non-manipulated dams. In total, 12 non-manipulated dams (n = 4 dams/
condition) were used as surrogate mothers to experimental offspring. Litter sizes were
maintained across the surrogate dams, who had their own pups to care for in addition to
experimentally-manipulated pups, such that all dams had 16–20 pups to care for following
cross-fostering. Experimental pups were identified by a tail mark (using a Sharpie™ marker)
until post-natal day 21, when pups were weaned from surrogate dams, identified via ear
notch, and housed 4–5 per cage until testing. Behavioural testing was carried out between
post-natal days 28 and 30. All cross-fostered pups (n = 30 male, n = 30 female pups;
yielding n = 15 pups/condition) survived to weaning and were subjected to behavioural
testing. At the time of testing, all juveniles were weighed and assessed in the object
recognition [hippocampus- and prefrontal cortex (PFC)-dependent] and open field
(hippocampus-dependent) tasks. There were no differences in the body weight of the pups
across groups at this time.
Behavioural Testing—All behavioural testing was conducted after 09:00 h, during the
dark phase of the 24 h light cycle. Rats were assessed in the open field task prior to the
object recognition task. This allows for assessment of anxiety-like behaviour and habituation
to the novel testing chamber prior to assessment of object recognition. All dependent
measures were hand recorded by an observer who was blind to the experimental condition of
the animals and by ANY-maze animal tracking software (Stoelting, Chicago, IL). There was
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greater than 95 % concordance between hand-collected and software-calculated data. As
such, the computer-generated data were used for analyses.
Open Field—Behaviour in the open field, such as exploration, and behaviour that is
indicative of anxiety, is dependent upon the hippocampus [30] and was examined as
previously-described prior to assessment in the cognitive task [17,31]. Briefly, the open field
consisted of an arena (76 × 57 × 35 cm) divided into a grid of 48 squares. The arena was
located in a brightly-lit testing room. Rats were placed in the lower right-hand corner and
allowed to explore the arena for 5 min. The number of entries made into all 48 squares (total
entries), and into the inner 8 squares (central entries), were recorded using animal tracking
software (as above). The tracking software uses the centre of an animal’s body in order to
objectively quantify grid entries in the maze. The number of total entries made in the task
was considered an index of exploratory/motor behaviour. The percentage of entries made
into the inner 8 squares as a function of all squares entered [(frequency of entries into the
inner 8 squares/frequency of entries into all squares) × 100] was utilised as an index of
reduced anxiety in order to minimise the contribution of any individual disparities in overall
locomotor behaviour.
Object Recognition—Object recognition, a working memory task that primarily relies on
an intact hippocampus and PFC [32], was used per previously published methods [16,17].
Briefly, rats were placed in an open field (76 × 57 × 35 cm) in a brightly-lit testing room
with two identical round objects (plastic toys in the shape of oranges; 6 cm diameter) for the
training phase of this task. Rats were allowed 3 min to explore the open field with the
objects. Following training, rats were placed in their home-cages in a dark, sound-dampened
room for 4 h. Rats were returned to the open field for the testing phase of this task, wherein,
one of the spherical objects was replaced with a cone-shaped object (a plastic toy in the
shape of a triangular buoy; 6.25 cm tall, 6 cm wide at base, 1 cm at apex). Rats were allowed
3 min to explore the open field with the familiar and novel objects. Exploration of the
objects was recorded via the animal tracking software. Rats did not show a side-preference
in their exploration of objects; however, placement of the novel object was counterbalanced
across treatment groups and testing sessions to minimise potential confounds. In this task, a
greater percentage of time spent exploring the object in the novel location as a function of
the total amount of time spent exploring both objects during testing [duration spent with
novel object/(duration spent with novel object + duration spent with familiar object) × 100]
was considered an index of enhanced cognitive performance.
Tissue Collection—Immediately following behavioural testing, offspring were
euthanised via rapid decapitation without anaesthetic. Trunk blood was collected in a chilled
glass culture test tube following decapitation, allowed to clot, centrifuged at 3,000 × g, and
serum was decanted. Whole brains were rapidly removed from the skull and frozen on dry
ice. All tissue were stored at −80 °C until radioimmunoassay for concentrations of
progesterone, DHP, 3α,5α-THP, 17β-oestradiol and corticosterone (serum only).
Tissue Preparation—The brains of offspring were thawed on ice. The hippocampus,
medial prefrontal cortex (mPFC), and diencephalon were grossly dissected as previously
described [33].
Radioimmunoassays for Steroid Hormones—Progesterone, DHP, 3α,5α-THP, 17β-
oestradiol, and corticosterone concentrations were measured as described below, using
previously reported methods [16,17].
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Radioactive Probes: [3H] progesterone (NET-208: specific activity = 47.5 Ci/mmol), and
[3H]3α,5α-THP (used for DHP and 3α,5α-THP, NET-1047: specific activity = 65.0 Ci/
mmol), [3H]oestradiol (NET-317: specific activity = 51.3 Ci/mmol), and [3H]corticosterone
were purchased from Perkin Elmer (Boston, MA).
Extraction of Steroids from Serum: Serum (300 μl) was incubated with water and 800
cpm of [3H] steroid, and 17β-oestradiol, progesterone, DHP, and 3α,5α-THP were extracted
with ether. Test tubes containing steroid and ether were snap frozen twice and evaporated to
dryness. Tubes containing lyophilised steroid were reconstituted with phosphate assay buffer
to the pre-lyophilised serum volume (300 μl). Corticosterone was extracted by heating at 60
°C for 30 min.
Extraction of Steroids from Brain Tissues: Progesterone, DHP, 3α,5α-THP, and 17β-
oestradiol were extracted from brain tissues following homogenization with a glass/glass
homogeniser in 50% methanol (MeOH), 1% acetic acid. Tissues were centrifuged at 3,000 x
g and the supernatant was subjected to chromatography using Sepak-cartridges equilibrated
with 50% MeOH:1% acetic acid. Steroids were eluted with increasing concentrations of
MeOH (50% MeOH followed by 100% MeOH). Solvents were removed using a speed drier
and samples were reconstituted in 350 μl assay buffer.
Antibodies: The progesterone antibody (P#337 from Dr. G.D. Niswender, Colorado State
University) was used at a 1:30,000 dilution and has very low (< 4%) cross-reactivity with
DHP and 3α,5α-THP [34]. This antibody typically binds between 30% and 50% of [3H]
progesterone and bound 48% in the present study. The DHP (X-947) and 3α,5α-THP
(#921412-5) antibodies were purchased from Dr. Robert Purdy (Veterans Medical Affairs,
La Jolla, CA) and used at a 1:5000 dilution. The DHP antibody cross-reacts with 3α,5α-THP
(100%), 5α-pregnan-3,20-dione (50%), 4-pregnen-3α-ol-20-one (50%), and progesterone
(17%) [35]. The 3α,5α-THP antibody cross-reacts with 3α-hydroxypregn-4en-20-one (84%)
and DHP (11%), and its β-isomer (7%), progesterone (6%), and pregnenolone (< 2%)
[35,36]. These antibodies typically bind between 40 and 60% of [3H] 3α,5α-THP and bound
47% in the present study. The corticosterone antibody (#B3-163, Endocrine Sciences) was
used at a 1:20,000 dilution and has little cross-reactivity with deoxycorticosterone (4%),
negligible (< 1%) cross-reactivity with cortisol, aldosterone, and progesterone [37]. This
antibody typically binds between 40 and 60% of [3H]corticosterone and bound 45% in the
present study. The 17β-oestradiol antibody (E#244, Dr. G.D. Niswender, Colorado State
University, Fort Collins, CO) was used at a 1:40,000 dilution and has negligible (< 1%)
cross-reactivity with oestrone, 17β-oestradiol, progesterone, and 17-hydroxyprogesterone
[38]. This antibody typically binds between 40% and 60% of [3H]17β-oestradiol and bound
54% in the present study.
Set-up and Incubation of Radioimmunoassays: Standard curves ranged from 0–8000 pg
for progesterone, DHP, and 3α,5α-THP, 0–1000 pg for 17β-oestradiol, and 0–4 ng for
corticosterone. Standards were added to assay buffer followed by addition of the appropriate
antibody and [3H]steroid. Total assay volumes were 800 μl for progesterone, 950 μl for DHP
and 3α,5α-THP, 800 μl for 17β-oestradiol, and 950 μl for corticosterone. All assays were
incubated overnight at 4 °C with the exception of corticosterone which was incubated for 60
min at room temperature.
Termination of Binding: Dextran-coated charcoal was rapidly added to assay tubes in
order to separate bound and free steroid. Following incubation with charcoal, samples were
centrifuged at 3000 x g and the supernatant was decanted into a glass scintillation vial with 5
ml scintillation cocktail. Steroid concentrations were calculated using the logit-log method
of Rodbard and Hutt [39], interpolation of standards, and correction for recovery with Assay
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Zap (Biosoft, Cambridge, UK). The inter- and intra-assay reliability co-efficients were:
progesterone - 0.11 and 0.10, DHP - 0.11 and 0.09, 3α,5α-THP - 0.09 and 0.09, 17β-
oestradiol - 0.07 and 0.06, and corticosterone - 0.04 and 0.06.
Statistical Analyses
Weight gain in the dams [expressed as a percentage of body weight; i.e. (body weight at GD
16/body weight at term) × 100], length of gestation (expressed in hours after 00:00h on GD
18 to parturition) and fecundity (mean number of pups per litter) were assessed via one-way
analyses of variance (ANOVA) with gestational manipulation as a factor (vehicle, 3α,5α-
THP, or finasteride administration). Behavioural and neuroendocrine status of offspring was
assessed via two-way ANOVAs with gestational manipulation (vehicle, 3α,5α-THP, or
finasteride administration) and sex (male or female) as factors. A ratio of progestogen
metabolites reduced from the parent hormone, progesterone (DHP+3α,5α-
THP:Progesterone), was calculated per previous methods [16], as an index of progesterone
utilization. Fisher’s PLSD post hoc tests were utilised to determine group differences. When
interactions were present, one-way ANOVAs with p value corrected for multiple
comparisons (given considerations of inflated error in post-hoc analyses [40]) were utilised
to determine simple main effects. Alpha level for statistical significance was p ≤ 0.05.
Simple regressions were performed to assess whether variances in behavior could be
explained by concentrations of steroid hormones, but significant relationships were not
observed for any measure.
Results
Inhibition of 5α-reductase during pregnancy decreased the length of gestation and the
number of pups found in the nest following parturition
Dam weights (mean ± SEM; n = 7/group) did not significantly differ on GD 16, prior to
manipulations (vehicle-administered control dam = 264 ± 10 g, 3α,5α-THP-administered
dams = 247 ± 2 g, finasteride-administered dams = 267 ± 12 g), nor did they significantly
differ at term (control dam = 302 ± 10 g, 3α,5α-THP-administered dams = 292 ± 3 g,
finasteride-administered dams = 292 ± 19 g). However, weight gained during pregnancy as a
percentage of body weight significantly differed among groups [F(2,18) = 5.08, p < 0.05].
While experimental groups were not different from vehicle-administered control dams (115
± 3 %), 3α,5α-THP-administered dams gained significantly more weight (118 ± 1 %) than
did the finasteride-administered dams (109 ± 3 %; p = 0.005).
Compared to treatment with vehicle (p = 0.004) or 3α,5α-THP (p = 0.02), blockade of 3α,
5α-THP formation with finasteride administration during gestational days 17–21,
significantly reduced the length of gestation [F(2,18) = 6.30, p < 0.05] (Fig. 1A).
Administration of 3α,5α-THP, during gestational days 17–21, did not significantly alter
gestational length compared to administration of vehicle (Fig. 1A).
In comparison to vehicle (p = 0.007) or 3α,5α-THP (p = 0.004) administration, finasteride
significantly reduced the number of pups/litter that were present following parturition
[F(2,18) = 6.69, p < 0.05] (Fig. 1B). Administration of 3α,5α-THP, compared to vehicle-
control manipulation, did not significantly alter fecundity (Fig. 1B).
Altering prenatal 3α,5α-THP availability influenced object recognition and locomotor
behaviour, but not anxiety-type behaviour
Prenatal blockade of 3α,5α-THP formation on GD 17–21 significantly impaired object
recognition in the juvenile offspring [F(2,84) = 4.31, p < 0.05]. Compared to prenatal
vehicle (p = 0.01) or 3α,5α-THP (p = 0.01) exposure, male and female offspring of mothers
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exposed to finasteride in late gestation spent significantly less time with the novel object
during testing, irrespective of sex (Fig. 2). Offspring born to dams that had been
administered 3α,5α-THP during GD 17–21 did not significantly differ from vehicle-exposed
control offspring in the object recognition task (Fig. 2). No sex differences were observed
for object recognition.
There was no significant main effect for locomotor behaviour in the open field, with respect
to prenatal manipulations. However, there was a significant interaction between treatment
and sex [F(2,84) = 3.23, p < 0.05], wherein only prenatal 3α,5α-THP administration
significantly increased the total number of entries made in the open field by females
compared to males (p = 0.0005; Table 1).
Gestational treatment did not significantly alter the anxiety-type behaviour among male or
female offspring (Fig. 3). However, irrespective of gestational manipulation, a significant
sex difference was observed, with males making a greater proportion of entries into the
center of the open field compared to females [F(1,84) = 21.69, p < 0.05], (Fig. 3).
Steroid concentrations in the hippocampus, medial prefrontal cortex, and diencephalon of
the juvenile offspring were altered by gestational manipulation of 3α,5α-THP availability
Administration of 3α,5α-THP, or inhibition of its formation from progesterone with
finasteride, influenced 3α,5α-THP concentrations in the hippocampus [F(2,84) = 7.97, p <
0.05], mPFC [F(2,84) = 4.35, p < 0.05], and/or diencephalon [F(2,84) = 4.63, p < 0.05] of
the juvenile offspring. Compared to vehicle, prenatal treatment with 3α,5α-THP
significantly increased 3α,5α-THP content in juvenile hippocampus (p = 0.05; Fig. 4),
mPFC (p = 0.007; Table 2), and diencephalon (p = 0.007; Table 2), regardless of sex.
Irrespective of sex, the hippocampus was the only region wherein prenatal finasteride
exposure significantly reduced 3α,5α-THP content of male and female offspring compared
to vehicle-exposed controls (p = 0.047) or 3α,5α-THP-exposed offspring (p = 0.0004; Fig.
4).
Progesterone content was also influenced by prenatal 3α,5α-THP and finasteride
manipulations in the juvenile hippocampus [F(2,84) = 5.89, p < 0.05], mPFC [F(2,84) =
11.54, p < 0.05], and/or diencephalon [F(2,84) = 12.63, p < 0.05]. Compared to vehicle-
treated offspring, prenatal 3α,5α-THP significantly reduced progesterone content in the
mPFC (p = 0.009) and diencephalon (p = 0.007) of male and female offspring, but not
hippocampus (Table 2). Prenatal finasteride treatment resulted in significantly greater
progesterone content in the mPFC (p = 0.04) and diencephalon (p = 0.03), but not
hippocampus (Table 2). Notably, progesterone utilization (ratio of metabolites to
progesterone) was altered in the hippocampus [F(2,84) = 5.93, p < 0.05], mPFC [F(2,84) =
5.36, p < 0.05] and diencephalon [F(2,84) = 6.23, p < 0.05]. Prenatal 3α,5α-THP treatment
significantly increased progesterone utilization in the juvenile hippocampus (p = 0.004),
mPFC (p = 0.004), and diencephalon (p = 0.004), of male and female offspring compared to
vehicle-exposed controls (Table 2). Prenatal finasteride exposure did not significantly
influence the ratio of progesterone to its metabolites.
Prenatal manipulations altered 17β-oestradiol content in the offspring hippocampus [F(2,84)
= 10.21, p < 0.05], mPFC [F(2,84) = 11.48, p < 0.05], and diencephalon [F(2,84) = 7.71, p <
0.05]. Irrespective of sex, prenatal 3α,5α-THP treatment significantly increased 17β-
oestradiol content in the hippocampus (p = 0.007), mPFC (p < 0.0001), and diencephalon
compared to vehicle-exposed controls (p = 0.003; Table 2). No differences were observed in
17β-oestradiol content in any of the brain regions studied following gestational finasteride
exposure.
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Some sex differences were observed in central progestogen formation. There was a
significant interaction [F(2,84) = 3.00, p = 0.05], whereby DHP content in the mPFC was
influenced by perinatal manipulations in a sex-dependent manner. In the male offspring,
prenatal 3α,5α-THP (p = 0.01) or finasteride treatment (p = 0.02) significantly increased
DHP content in the mPFC compared to that seen in the vehicle-exposed males; however, no
differences were observed across the female groups (Table 2). Additionally, sex differences
were observed wherein females had greater progesterone [F(1,84) = 10.31, p < 0.05] and
DHP [F(1,84) = 8.28, p < 0.05] concentrations in the diencephalon, and lower 17β-
oestradiol levels in the hippocampus [F(1,84) = 8.28, p < 0.05] and mPFC [F(1,84) = 5.46, p
< 0.05] compared to the male offspring (Table 2).
Circulating steroid concentrations in the juvenile offspring were influenced by gestational
manipulation of 3α,5α-THP availability
Serum corticosterone concentrations showed a significant interaction with gestational
manipulation and sex [F(2,84) = 9.51, p < 0.05]. Prenatal 3α,5α-THP administration resulted
in increased corticosterone concentration in both male (p = 0.02) and female (p = 0.03)
offspring compared to their respective same-sex controls (Table 3). Prenatal finasteride
treatment significantly increased circulating corticosterone concentrations compared with
same-sex controls, in the female (p < 0.0001) but not the male offspring.
Serum progesterone concentrations were significantly reduced [F(2,84) = 5.05, p < 0.05] in
3α,5α-THP-exposed females compared to vehicle-exposed females (p = 0.045), but no such
differences were observed for males (Table 3). There was also an interaction for serum
measurements reflecting progesterone utilization to be enhanced [F(2,84) = 4.01, p < 0.05]
among 3α,5α-THP-exposed females compared to vehicle-exposed females (p = 0.02); this
was not observed among males (Table 3). No differences were observed in serum
concentrations of 17β-oestradiol, DHP, or 3α,5α-THP concentrations in any of the groups.
Discussion
The hypothesis that inhibition of 3α,5α-THP formation via finasteride would reduce the
length of gestation and pup viability is supported by the results of the present study. While,
3α,5α-THP administration to pregnant dams between GD 17–21 did not extend pregnancy or
alter fecundity, finasteride administration significantly decreased gestational length and the
number of pups found after birth, compared to dams administered vehicle. These findings
are in accord with the known teratogenic effects of finasteride when administered to
pregnant women [41] and support the notion that 5α-reduced metabolites play an important
role in the mechanisms that maintain pregnancy and facilitate parturition [42]. Given that
systemic finasteride (50 mg/kg/ml) has also been demonstrated to enhance circulatory
progesterone among late-pregnant Sprague-Dawley rats [25], 5α-reduction of progesterone
may underlie a critical mechanism in regulating rodent parturition. In support, female mice
with a disruption in the gene encoding for 5α-reductase type I have poor pregnancy
outcomes, including embryonic resorption and reduced litter size [43].
An important question to consider is: what happened to the finasteride-exposed pups that
were gestated but not observed following birth? Pup resorption is unlikely to explain the
reduced litter sizes observed among finasteride-administered dams given the proximity of
the manipulations to the end of pregnancy and the similarities in weights of dams late in
gestation. As such, reductions in offspring number may be attributable to either death in
utero or at birth (as a consequence of being born prematurely) and/or cannibalism/
infanticide at birth (perhaps as a consequence of being born under-developed or as a
consequence of finasteride-induced disruption of maternal behaviour). Indeed, finasteride
administration delays the onset of maternal behaviour among primigravid Sprague-Dawley
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rats [25]. While deceased pups were not found in any dam cages, it cannot be ruled out that
dams cannibalised pups between observation periods. Despite average dam weights not
being significantly different at term, dams administered finasteride did gain a significantly
lower percentage of weight by term than did 3α,5α-THP-administered dams, which may be
indicative of fetal loss or under-development at birth. As such, actions of 5α-reduced
metabolites may be critical for the maintenance of rodent pregnancy and/or offspring
survival.
Another important question to consider is: what are the mechanisms through which 3α,5α-
THP exerts its effects to maintain pregnancy? One possible mechanism may be via
inhibitory actions to dampen HPA axis or neurohypophysial oxytocin responses to stress. In
lambs, prenatal glucocorticoids promote preterm birth [44] and studies utilizing sheep
models have demonstrated low fetal birth weight following prenatal exposure to synthetic
glucocorticoids [45]. Inhibitory influences of 3α,5α-THP extend to magnocellular oxytocin
neurones in late pregnancy [46]. At this time, 3α,5α-THP prevents oxytocin neurones from
responding to stimuli, such as stressors [47,48]. Since oxytocin is an important and potent
stimulator of uterine contractions at term, this action of 3α,5α-THP may minimize the risk of
preterm birth through maintaining quiescence of oxytocin neurones. As such, inhibitory
actions of 3α,5α-THP on oxytocin-producing neurones may be important for maintaining
gestation [48] and may play an important role in preventing premature delivery.
The hypotheses that exposure to 3α,5α-THP, or inhibition of its formation by finasteride,
would enhance or perturb cognitive behaviour of surviving offspring, respectively,
concomitant with altered progestogen availability in the brains of offspring, were supported,
in part. While exposure to 3α,5α-THP did not alter offspring cognitive performance,
offspring born to dams administered finasteride displayed significantly poorer performance
in the object recognition task compared to those administered vehicle. Of the brain regions
investigated, prenatal finasteride had lasting effects to reduce 3α,5α-THP levels only in the
hippocampus of the juvenile male and female offspring. These data are in accord with
previous findings in adults rats, which show that restraint stress during late pregnancy (GD
17–20) reduces maternal hippocampal 3α,5α-THP levels [49]. Moreover, acutely-
administered 3α,5α-THP improves memory in hippocampus- and frontal cortex-mediated
tasks of adult rats [50]. We have recently observed prenatal exposure to stressors (thrice
daily restraint or chronic unpredictable stressors) to reduce cognitive performance in
juveniles concomitant with dysregulation in central progestogen formation [16,17]. The
present data indicate that inhibition of 5α-reduction during late pregnancy can have lasting
effects to alter cognitive performance into adolescence.
Some of the effects of finasteride to reduce cognitive performance may be due, in part, to a
role of 3α,5α-THP as a neurotrophic modulator. The hippocampus is particularly sensitive to
glucocorticoid exposure during fetal development [27] and prenatal stress can promote
reduced hippocampal volume and decreased dendritic spine density [17,51]. Others have
demonstrated that rats administered 3α,5α-THP prior to a prefrontal cortex-targeted
traumatic brain injury have less central cell loss and less cognitive impairment on
hippocampus-dependent tasks following recovery [52]. 3α,5α-THP has similar
neuroprotective effects following ischemic brain injury in adult rats [53]. Thus, inhibition of
5α-reduction during pregnancy perturbs later cognitive performance of juvenile offspring,
which may be due in part to reduced neurotrophic actions of 3α,5α-THP.
Our hypotheses that enhanced exposure to 3α,5α-THP, or inhibition of its formation by
finasteride, would alter anxiety-type behaviour of the surviving offspring was not supported.
Neither prenatal exposure to 3α,5α-THP, nor finasteride, significantly altered anxiety-like
behaviour in the open field test. We did, however, observe a significant sex difference,
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wherein juvenile males demonstrated significantly lower anxiety-type behaviour than
females. This finding is in contrast to studies with adult, group-housed rats and mice, in
which females typically demonstrate lower anxiety-type behavior than do males [54–56].
However, when the influence of gonadal hormones is taken into account, we and others have
observed that reductions in anxiety-type behaviour of females coincide with cyclical
enhancement of gonadal progestogen levels [57,58]. Given that the present studies were
performed in juvenile rats (when the activational role of gonadal hormones can be assumed
to be minimal), it is of interest that a sex difference was observed, although the explanation
is not clear. Prenatal stress differentially affects anxiety-type behaviour in male and female
offspring [59,60] or commensurately enhances anxiety-type behavior in both sexes [61].
Some of these apparent discrepancies may be due to variations in the prenatal stress
paradigm used and/or may result from differences in the strain of rat used (given that
opposing prenatal stress effects have been observed for morphological and affective
abberations observed among Sprague-Dawley vs. Long-Evans rats) [62–65].
In addition to enhanced anxiety-type behavior among female offspring, prenatal finasteride
treatment elevated corticosterone levels among females only, which may contribute to the
male bias observed for anxiety-type behaviour in the open field task. Among all juveniles,
corticosterone levels were observed to be relatively low. Long-Evans rats [66] have
reportedly lower concentrations of circulatory corticosterone in adolescence and adulthood
compared to other strains, such as Sprague-Dawley rats [67]. Albeit, corticosterone levels
are expected to be lower among juvenile rats compared to adults. In support, even after a
significant stressor (confinement to an open elevated arm for 15 mins), corticosterone
concentrations are lower among pubescent Long-Evans rats (~1–3 μg/dl at 45 days of age)
compared to adult Long-Evans rats (~3–12 μg/dl at 70 days of age [66]). Prior investigations
in rats indicate that males and females can have a divergent 5α-reductase type II profile
under stress (with males displaying increased, and females decreased, mRNA expression in
the prefrontal cortex) [68], which may be involved in these effects. The extent to which
effects of prenatal finasteride exposure persists, are ameliorated, or are exacerbated, in
adulthood is not known and will be the target of future investigation. In addition, the
characterization of genetic differences that influence affective and HPA axis profiles should
be systematically addressed in future studies using different rat strains.
Enhancement of prenatal 3α,5α-THP exposure influenced neuroendocrine programming.
While prenatal 3α,5α-THP administration did not significantly alter cognitive performance
or affective behaviour compared to vehicle-control manipulations, salient changes in the
neuroendocrine milieu were observed among 3α,5α-THP-exposed, juvenile rats. Hence,
prenatal 3α,5α-THP administration significantly enhanced 17β-oestradiol and 3α,5α-THP
concentrations in all brain regions examined. The enhancement of 17β-oestradiol level may
be due, in part, to actions of 3α,5α-THP that dampen corticotropin releasing hormone (CRH)
transcription [69]. Typically, CRH inhibits gonadotropin releasing hormone secretion via
enhancement of β-endorphin [70]; hence, actions of 3α,5α-THP that reduce CRH secretion
may promote oestradiol accumulation in the brain that would otherwise be regulated via
negative feedback. In addition, prenatal 3α,5α-THP exposure promoted modestly elevated
corticosterone levels in response to behavioural testing. At the time of puberty, patterns for
distinct GABAergic receptor subunit composition are observed in rodents which can
attenuate neurosteroid efficacy in HPA axis modulation [71]. This transient GABA receptor
subunit expression may underlie the observed effects for prenatal 3α,5α-THP to increase
corticosterone at the time of puberty. Future investigations will be needed to assess these
effects in adulthood. As such, the gestational 3α,5α-THP milieu may have lasting effects to
influence offspring neuroendocrine development.
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In conclusion, these data demonstrate that inhibition of 5α-reductase activity during late
pregnancy (GD 17–21) can induce preterm birth and reduce fecundity, as well as having
long-term consequences for cognitive function and hippocampal 3α,5α-THP formation in
the surviving offspring. These findings may present a paradigm to investigate the
involvement of 3α,5α-THP in a rodent model of preterm birth. Future investigations will aim
to utilize 3α,5α-THP administration to prevent the negative effects of finasteride on birth
outcomes. A limitation of this study is that litter birth weights were not assessed. While,
there were no differences in the weight of the juvenile offspring across groups at the time of
behavioural testing, assessment of differences at birth may be indicative of fetal effects that
are transient or pervasive throughout life. Future investigations should aim to assess effects
from birth throughout the lifespan. In addition, further investigation of the reduction in
number of viable offspring is warranted given that it remains to be delineated how blockade
of 5α-reduction in pregnancy reduces fecundity.
These data have important clinical implications. Among women that are at-risk for preterm
birth, intramuscular injections of 17α-hydroxyprogesterone (17α-OHP) reduce the incidence
of parturition before 34 or 37 weeks of gestation, respectively [20]; albeit, effectiveness of
17α-OHP is not always observed among women with a history of prior preterm birth and/or
pregnancy complications [72]. Analyses of 11 randomised, controlled trials (2,425 pregnant
women) revealed that treatment with progesterone, compared to placebo, significantly
reduced the incidence of birth before 34 weeks of gestation among those with a history of
preterm birth [73]. Metabolism to 3α,5α-THP may partly underlie the mechanisms
mediating efficacy of progesterone as a tocolytic agent. It should be noted that the decrease
in peripheral progestogen concentrations that precedes parturition in rodents is not
characteristic of human pregnancy. In women, peripheral progestogen levels are maintained
via the placenta, which acts as a progestogen-secreting gland [74]. However, concentrations
of 3α,5α-THP have been reported to be markedly reduced in the umbilical artery, umbilical
vein, maternal cubital vein, and amniotic fluid in the last three weeks of birth compared to
other times in the last trimester of pregnancy in women [12]. Moreover, changes in central
3α,5α-THP levels are observed in rats prior to parturition and cannot be directly assessed in
women [13]. Preterm birth, which occurs relatively frequently in human pregnancy, may
deprive the brain of key steroid exposure. Further investigation is required to elucidate the
roles of 3α,5α-THP in preterm birth and offspring neurodevelopment.
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Figure 1. Hours until parturition after day 18 of gestation and number of viable pups per litter
(A) The mean length of gestation is expressed as the number of hours after 00:00 h on
gestational day 18 until parturition (mean + SEM) among dams administered vehicle (oil,
control; n = 7), 3α,5α-THP (10 mg/kg daily, n = 7), or finasteride (50 mg/kg daily, n = 5) on
gestational days 17–21 (mean + SEM). (B) The mean number of viable pups per litter that
were found at parturition (mean + SEM), born to dams administered either vehicle, 3α,5α-
THP, or finasteride (as described above). * indicates significant difference from control rats
via one-way ANOVA, p < 0.05.
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Figure 2. Cognitive performance in the male and female offspring in the object recognition task
Data are the percentage time (in 3 min; mean + SEM) spent investigating a novel object in
the object recognition task among male and female offspring (n = 15/group) that were
prenatally-exposed to vehicle (oil, control), 3α,5α-THP (10 mg/kg daily), or finasteride (50
mg/kg daily) on days 17–21 of gestation. ** indicates a significant main effect for
finasteride-exposed offspring to differ from control, or 3α,5α-THP exposed, offspring
(irrespective of sex) via two-way ANOVA, p ≤ 0.05.
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Figure 3. Anxiety-type behavior of the male and female offspring in the open field test
Data are the percentage of entries (in 5 min; mean + SEM) into the center of an open field
among male and female offspring (n = 15/group) that were prenatally-exposed to vehicle
(oil, control), 3α,5α-THP (10 mg/kg daily), or finasteride (50 mg/kg daily) on days 17–21 of
gestation. * indicates a significant main effect wherein females differ from males via two-
way ANOVA, p < 0.05.
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Figure 4. Hippocampal 3α,5α-THP concentrations in juvenile male and female offspring
Hippocampal 3α,5α-THP concentrations (mean + SEM) in male and female offspring (n =
15/group) that were prenatally-exposed to vehicle (oil, control), 3α,5α-THP (10 mg/kg
daily), or finasteride (50 mg/kg daily) on days 17–21 of gestation. ** indicates a significant
main effect for offspring exposed to 3α,5α-THP or finasteride to differ from control
offspring (irrespective of sex) via two-way ANOVA, p < 0.05.
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